Diabetes News and Research

Latest Diabetes News and Research

Study links high and low levels of "good" cholesterol with dementia risk

Having either high or low levels of high-density lipoprotein (HDL) cholesterol, or "good" cholesterol, is tied to a small increased risk of dementia in older adults, according to a study published in the October 4, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

4 Oct 2023

Research identifies characteristics linked with higher risk of sudden cardiac arrest in people with type 2 diabetes

New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has identified a range of characteristics associated with a higher risk of sudden cardiac arrest in individuals with type 2 diabetes.

4 Oct 2023

Early metformin therapy falls short in curbing gestational diabetes woes

In a significant randomized clinical trial, early metformin therapy was tested for its potential to lessen insulin dependence and enhance glycemic control in gestational diabetes-afflicted pregnant women; however, it yielded no improvements in diabetes symptoms. While metformin reduced maternal weight gain, its effects on primary diabetes symptoms and other secondary outcomes like infant weight gain were mixed, indicating a need for further focused research to unravel these associations.

4 Oct 2023

The cut-off for HbA1c-based diagnosis of diabetes may be too high in women

Researchers compare the distribution of glycated hemoglobin (HbA1c) levels in premenopausal women and men of the same age.

4 Oct 2023

Antiviral treatment emerges as a potential game-changer in curbing type 1 diabetes progression

New research from the University of Oslo reveals antiviral drugs could help preserve insulin production in children newly diagnosed with type 1 diabetes, potentially slowing down or even preventing the disease. The study, building on earlier findings linking enterovirus to type 1 diabetes, showed that antiviral treatment led to maintained insulin production, proposing a new therapeutic avenue to treat and mitigate the progression of type 1 diabetes.

3 Oct 2023

New insights into how smoking influences certain metabolites to increase type 2 diabetes risk

New research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct) finds that cigarette smoking increases the risk of developing type 2 diabetes in part by affecting a variety of metabolites-;small chemicals produced in the processes of metabolism-;that circulate in the bloodstream.

3 Oct 2023

Universal screening: A game-changer in early detection and management of type 1 diabetes

Dr. Emily K. Sims discusses the crucial role of universal type 1 diabetes (T1D) screening in early detection, especially in individuals without a family history, at the EASD Annual Meeting. This proactive approach, aligned with disease-modifying therapies, aims to prevent severe diabetic ketoacidosis episodes, marking a stride towards better management of T1D.

3 Oct 2023

Type 2 diabetes at age 30 linked to shorter life expectancy

An individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an international team of researchers has warned.

3 Oct 2023

Type 2 diabetes screening in Accident and Emergency departments could detect thousands of new cases

The introduction of screening for type 2 diabetes in Accident and Emergency (A&E) departments could uncover thousands of previously undiagnosed cases every year, suggests new research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct).

3 Oct 2023

Stem cell-derived islet cell therapy shows promise for type 1 diabetes

Six adults with type 1 diabetes (T1D) treated with stem cell-derived islet cells (VX-880) have shown improved blood sugar control with three participants achieving insulin independence, according to new research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct).

3 Oct 2023

Study confirms effectiveness of Pooled Cohort Equation for assessing cardiovascular risk

A recent study based on real-world community patient data confirms the effectiveness of the Pooled Cohort Equation (PCE), developed by the American Heart Association and the American College of Cardiology in 2013.

3 Oct 2023

Stereotactic radiation therapy offers new hope for older adults with inoperable kidney cancer

Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests.

3 Oct 2023

Study finds link between food insecurity and severe hypoglycemia

New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has found that severe hypoglycemia is more than twice as common among adults with diabetes who struggle to afford food.

3 Oct 2023

Lower HbA1c threshold could lead to earlier diagnosis, treatment of type 2 diabetes in women under 50

New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October) and published in the journal Diabetes Therapy suggests that the diagnosis threshold for type 2 diabetes (T2D) should be lowered in women aged under 50 years, since natural blood loss through menstruation could be affecting their blood sugar management.

3 Oct 2023

New hope for hispanic type 2 diabetes patients: pharmacist intervention cuts A1c levels

Researchers examined whether pharmacist-led interventions improved adherence to medications and guideline-concordant care based on changes in hemoglobin A1C (HbA1C) levels and systolic blood pressure among Hispanic type 2 diabetes patients.

3 Oct 2023

Could seaweeds be the superfood and medicine of the future?

Researchers consolidate the diverse nutritional and medicinal benefits of seaweeds, touting their potential in food, nutraceuticals, and pharmaceuticals. The study also highlights challenges and opportunities in industrial applications, calling for more research to optimize extraction and refinement processes.

2 Oct 2023

Drink up but hold the sugar: Unsweetened coffee linked to weight loss, study reveals

A recent study in The American Journal of Clinical Nutrition reveals that increasing the intake of unsweetened coffee, whether caffeinated or decaffeinated, is associated with reduced weight gain. Adding sugar to coffee, however, could negate these health benefits.

2 Oct 2023

Preterm birth risk highlighted in Stanford-led study on sleep and activity during pregnancy

Researchers developed series2signal, a novel, state-of-the-art prediction model that used wearable data from pregnant women to predict gestational age as a proxy for the progression of pregnancy and the likelihood of poor pregnancy outcomes, especially preterm birth, based on wearable-detected changes in maternal sleep quality and physical activity levels.

2 Oct 2023

Mogrify extends Series A financing to $46 million USD

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.

From Mogrify 2 Oct 2023

Ginger shows promise as a natural defense against autoimmune diseases

Comprehensive study reveals that whole ginger extracts have a significant impact on inhibiting neutrophil hyperactivity, a key factor in autoimmune diseases like APS and lupus. Consuming ginger for just a week showed promising results in both animal models and human trials, positioning it as a natural and affordable treatment option for a range of autoimmune disorders.

2 Oct 2023

Diabetes News and Research

Latest Diabetes News and Research

Study links high and low levels of "good" cholesterol with dementia risk

Research identifies characteristics linked with higher risk of sudden cardiac arrest in people with type 2 diabetes

Early metformin therapy falls short in curbing gestational diabetes woes

The cut-off for HbA1c-based diagnosis of diabetes may be too high in women

Antiviral treatment emerges as a potential game-changer in curbing type 1 diabetes progression

New insights into how smoking influences certain metabolites to increase type 2 diabetes risk

Universal screening: A game-changer in early detection and management of type 1 diabetes

Type 2 diabetes at age 30 linked to shorter life expectancy

Type 2 diabetes screening in Accident and Emergency departments could detect thousands of new cases

Stem cell-derived islet cell therapy shows promise for type 1 diabetes

Study confirms effectiveness of Pooled Cohort Equation for assessing cardiovascular risk

Stereotactic radiation therapy offers new hope for older adults with inoperable kidney cancer

Study finds link between food insecurity and severe hypoglycemia

Lower HbA1c threshold could lead to earlier diagnosis, treatment of type 2 diabetes in women under 50

New hope for hispanic type 2 diabetes patients: pharmacist intervention cuts A1c levels

Could seaweeds be the superfood and medicine of the future?

Drink up but hold the sugar: Unsweetened coffee linked to weight loss, study reveals

Preterm birth risk highlighted in Stanford-led study on sleep and activity during pregnancy

Mogrify extends Series A financing to $46 million USD

Ginger shows promise as a natural defense against autoimmune diseases

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diabetes News and Research

Latest Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in